Oxime-based inhibitors of glucose transporter 1 displaying antiproliferative effects in cancer cells
- 1 December 2013
- journal article
- Published by Elsevier BV in Bioorganic & Medicinal Chemistry Letters
- Vol. 23 (24), 6923-6927
- https://doi.org/10.1016/j.bmcl.2013.09.037
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- A Small-Molecule Inhibitor of Glucose Transporter 1 Downregulates Glycolysis, Induces Cell-Cycle Arrest, and Inhibits Cancer Cell Growth In Vitro and In VivoMolecular Cancer Therapeutics, 2012
- Anticancer Agents That Counteract Tumor GlycolysisChemMedChem, 2012
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Small compound inhibitors of basal glucose transport inhibit cell proliferation and induce apoptosis in cancer cells via glucose-deprivation-like mechanismsCancer Letters, 2010
- Novel inhibitors of basal glucose transport as potential anticancer agentsBioorganic & Medicinal Chemistry Letters, 2010
- GLUT1 as a therapeutic target in hepatocellular carcinomaEmerging Therapeutic Targets, 2009
- 18F-FDG PET and PET/CT in the Evaluation of Cancer Treatment ResponseJournal of Nuclear Medicine, 2009
- Glut-1 antibodies induce growth arrest and apoptosis in human cancer cell linesCancer Letters, 2007
- Overexpression of glut1 and glut3 in stage I nonsmall cell lung carcinoma is Associated with poor survivalCancer, 1997
- Na+-Glucose Cotransporter Inhibitors as Antidiabetics. I. Synthesis and Pharmacological Properties of 4'-Dehydroxyphlorizin Derivatives Based on a New Concept.CHEMICAL & PHARMACEUTICAL BULLETIN, 1996